CClinicalTrials.gg
CompletedNCT00717392Updated Mar 1, 2013

Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders

An observational study in Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder, sponsored by Sheba Medical Center. Completed at 1 site in Israel. Open to participants aged 5 Years to 17 Years. Per ClinicalTrials.gov, last updated 2013-03-01.

Sponsored by Sheba Medical Center · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
40
Ages
5 Years to 17 Years
Sex
All
01

Study summary

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. The purpose of the current research is to evaluate the efficacy of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy will show better outcomes than children with the same problems who are not treated with hippotherapy.

Read the detailed description

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. Most studies that tested hippotherapy were uncontrolled and focused on motor problems, such as cerebral palsy. Today, hippotherapy is used for various developmental problems such as Attention deficit / Hyperactivity disorder (ADHD) and Autism spectrum disorder (ASD), without clear information about its efficacy for these populations.

The purpose of the current research is to evaluate the efficacy of 6 months of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy for 6 months will show better outcomes than children with the same problems who are not treated with hippotherapy.

Assessment:

  • BRIEF questionnaire
  • Stony Brook Questionnaire

All questionnaires will be applied at the beginning of the study and after 6 months.

02

Conditions studied

  • Attention Deficit Hyperactivity Disorder
  • Autism Spectrum Disorder

Keywords

  • ADHD
  • ASD
03

In context

Autism Spectrum Disorder

1,727 studies on the registry are indexed under Autism Spectrum Disorder; 504 are open to participants now.

This study's enrollment of 40 is below the median of 102 across 321 observational studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hippotherapy subjects will be taken from horseback riding farms. Control subjects will be taken from a tertiary care clinic.

Inclusion criteria

  • Age: 5-17 years.
  • A diagnosis of ADHD or ASD.

Exclusion criteria

Exclusion Criteria:

  • None.
05

Study design

Time perspective
Prospective
Enrollment
40 participants (actual)

Groups and cohorts

  • Hippotherapy_ADHD

    10 children with ADHD who receive hippotherapy

  • Hippotherapy_ASD

    10 children with ASD who receive hippotherapy

  • Control_ADHD

    10 children with ADHD who DO NOT receive hippotherapy

  • Control_ASD

    10 children with ASD who DO NOT receive hippotherapy

06

What researchers measure

Primary outcomes

  1. Improving the parameters of autism

    Repetitive behaviors Eye contact Communication

    Time frame: Repetitive behaviors

07

Study locations

1 site
  • Weinberg Child Development Center, Sheba Medical Center, Tel-Hashomer
    Ramat-Gan, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00717392
Lead sponsor
Sheba Medical Center
Responsible party
Dr. Lidia Gabis MD (Director, The Weinberg Child Development Center, Sheba Medical Center) — Principal investigator
First posted
Jul 17, 2008
Start date
Sep 2008
Primary completion
Jun 2011
Completion
Jul 2012
Last update
Mar 1, 2013

Study contacts

Lidia Gabis, MD
principal investigator · Sheba Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion